Offstream
news

Egypt's drug regulator issues an emergency use authorization for Merck's Molnupiravir anti-COVID-19 drug.
2022-01-24

Merck & Co. and its partner Ridgeback Biotherapeutics sign an agreement with UNICEF to distribute up to 3 million courses of their COVID-19 antiviral pill molnupiravir to 100 low and middle-income countries in the first half of the year.
2022-01-18

The Ministry of Health and Family Welfare issues emergency use authorizations for the Covovax vaccine manufactured by the Serum Institute of India and the Corbevax vaccine. The ministry also issues an emergency use authorization for Merck & Co.'s anti-viral drug Molnupiravir.
2021-12-28

The Food and Drug Administration grants emergency use authorization for Merck & Co.'s antiviral COVID-19 oral pill named Molnupiravir for at-risk individuuals.
2021-12-23

The Danish Health Authority approves the usage of the Molnupiravir antiviral pill developed by Merck & Co. for at-risk patients with symptoms, becoming the first EU country to authorize the usage of this drug.
2021-12-16

The government announces that they will obtain 1.6 million doses of Merck & Co.'s molnupiravir and have also increased hospital capacities for COVID-19 patients to 30% in order to prepare for a sixth wave of the pandemic.
2021-11-12

The Medicines and Healthcare products Regulatory Agency grants conditional authorisation to Merck's molnupiravir, which can be used to treat symptomatic COVID-19 patients, making the United Kingdom the first country to approve the world's first COVID-19 antiviral oral drug.
2021-11-4

Merck & Co. signs a licensing agreement with the UN-backed Medicines Patent Pool that will allow more companies to manufacture generic versions of its experimental oral antiviral COVID-19 treatment molnupiravir with a royalty-free license that will apply to 105 low- and middle-income countries.
2021-10-27

U.S. President Joe Biden announces that Merck & Co. will produce single-shot Johnson & Johnson vaccine to help his administration goal for vaccinating every adult by the end of May.
2021-03-2

Merck & Co. agrees to buy Idenix Pharmaceuticals for US$3.85 billion.
2014-06-9